Orchestra BioMed Holdings (OBIO) Balance Sheet: Assets & Liabilities

Orchestra BioMed Holdings (OBIO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Orchestra BioMed Holdings reported total assets of $114.86M and total liabilities of $51.48M. Shareholders' equity was $63.38M, up 92.3% from $32.96M a year earlier. Total debt stood at $15.96M against $106.51M in cash and short-term investments, a net cash position of $90.56M. That puts debt-to-equity at 0.25, compared with 0.50 a year earlier.

Orchestra BioMed Holdings Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Orchestra BioMed Holdings, Inc. (OBIO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Mar 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	34.69	22.26	22.26	30.56	19.78	9.94	20.34
Short-Term Investments	71.82	44.55	44.55	57.04	64.00	0.96	15.45
Cash & Short-Term Investments	106.51	66.81	66.81	87.60	83.79	10.90	35.79
Accounts Receivable	0.10	0.09	0.09	0.10	0.10	0.12	0.17
Inventory	0.31	0.17	0.17	0.15	0.28	0.07	0.07
Other Current Assets	0.99	2.09	2.09	1.27	0.53	0.23	0.23
Total Current Assets	107.91	69.17	69.17	89.11	84.69	11.32	36.25
Non-Current Assets
Property, Plant & Equipment (Net)	3.21	3.49	3.49	2.83	3.68	1.12	1.03
Long-Term Investments	2.50	2.50	2.50	2.50	2.50	0.40	0.19
Other Non-Current Assets	1.24	1.02	1.02	0.77	4.71	0.69	0.63
Total Non-Current Assets	6.95	7.00	7.00	6.10	10.88	2.21	1.84
Total Assets	114.86	76.17	76.17	95.21	95.57	13.53	38.09
Current Liabilities
Accounts Payable	6.10	5.13	5.13	2.90	3.97	2.03	1.77
Short-Term Debt	0.75	0.55	-	0.65	0.70	2.00	4.00
Current Portion of Long-Term Debt	-	-	-	-	-	2.00	4.00
Accrued Liabilities	9.89	-	6.08	2.49	5.38	0.67	1.41
Deferred Revenue	0.00	4.44	4.44	2.51	6.44	5.54	5.80
Other Current Liabilities	9.89	6.08	-	5.15	7.47	2.67	1.38
Total Current Liabilities	16.74	16.21	16.21	11.21	18.57	12.24	14.36
Non-Current Liabilities
Long-Term Debt	15.20	15.98	14.29	1.04	11.17	3.67	5.46
Deferred Tax Liabilities	0.00	0.00	-	-14.92	0.00	0.00	0.00
Other Non-Current Liabilities	19.54	0.04	11.03	14.92	0.20	51.99	0.24
Total Non-Current Liabilities	34.74	27.01	27.01	15.96	24.47	72.52	72.27
Total Liabilities	51.48	43.22	43.22	27.17	43.04	84.76	35.18
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00	160.00	0.00
Retained Earnings	-362.58	-309.88	-309.88	-248.85	-199.73	-166.13	-143.11
Accumulated Other Comprehensive Income	0.06	0.05	0.05	-0.01	-0.01	-211.45	0.00
Additional Paid-in Capital	416.08	342.78	342.78	316.90	252.27	94.89	94.57
Shares Outstanding	57.03	-	38.19	35.78	31.61	31.61	-
Total Stockholders' Equity	63.38	32.96	32.96	68.04	52.53	-71.23	2.91
Total Liabilities & Equity	114.86	76.17	76.17	95.21	95.57	13.53	38.09

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Orchestra BioMed Holdings Balance Sheet

How much debt does Orchestra BioMed Holdings have?

Orchestra BioMed Holdings had total debt of $15.96M as of Dec 31, 2025, against $106.51M in cash and short-term investments. Its debt-to-equity ratio was 0.25. Total debt was $16.53M a year earlier.

What are Orchestra BioMed Holdings's total assets?

Orchestra BioMed Holdings reported total assets of $114.86M as of Dec 31, 2025, up 50.8% from $76.17M a year earlier. Total liabilities were $51.48M.

What is Orchestra BioMed Holdings's shareholders' equity?

Orchestra BioMed Holdings's shareholders' equity was $63.38M as of Dec 31, 2025, or about $1.11 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition